On July 14, 2023 Aravive, Inc. (Nasdaq: ARAV, "the Company"), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease reported that Gail McIntyre, Ph.D., DABT, Chief Executive Officer will be participating in a fireside chat at the William Blair Innovator Series: Transitioning Biotech Breakthroughs to Commercial Success being held virtually on July 18, 2023 (Press release, Aravive, JUL 14, 2023, View Source [SID1234633239]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

William Blair’s Innovator Series: Transitioning Biotech Breakthroughs to Commercial Success
Format: Fireside Chat with Aravive (ARAV)
Date/Time: Tuesday, July 18, 2023 at 12:00-12:45 PM ET
Host: Andy Hsieh, Ph.D., Biotech Research Analyst, William Blair
Presenter: Gail McIntyre, Ph.D., DABT, CEO, Aravive
Webcast: Conference attendees can check the schedule for more details or reach out to their William Blair salesperson.

A replay of the session will be available for 7 days following the event through the Aravive Events & Presentations section of the website View Source